Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	Manufacturers	Review Status	Status Date	View
JYSB2100053	依洛硫酸酯酶α注射液	elosulfase alfa	Injection	Biological Products	Supplementary Application	2021-02-23	百傲万里(上海) 生物医药技术咨询有限公司	Baiao Wanli (Shanghai) Biomedical Technology Consulting Co Ltd;Vetter Pharma-Fertigung Gmbh & Co KG;Biomarin International Ltd	In Review	2021-02-22	view
JYSB2100014	依洛硫酸酯酶α注射液	elosulfase alfa	Injection	Biological Products	Supplementary Application	2021-01-20	百傲万里(上海) 生物医药技术咨询有限公司	Baiao Wanli (Shanghai) Biomedical Technology Consulting Co Ltd;Vetter Pharma-Fertigung Gmbh & Co KG;Biomarin International Ltd	Filed	2021-01-22	view
JYSB1900044	Elosulfase alfa注射用浓溶液	elosulfase alfa	Injection	Biological Products	Supplementary Application	2019-02-11	百傲万里(上海) 生物医药技术咨询有限公司	Baiao Wanli (Shanghai) Biomedical Technology Consulting Co Ltd;Vetter Pharma-Fertigung Gmbh & Co KG;Biomarin International Ltd	Certificate Issued	2019-05-28	view
JXSL1700009	Elosulfase alfa注射用浓溶液	elosulfase alfa	Injection	Biological Products	Import Drug Application	2017-02-13	百傲万里(上海) 生物医药技术咨询有限公司	Baiao Wanli (Shanghai) Biomedical Technology Consulting Co Ltd;BioMarin Europe Ltd	Certificate Issued	2019-05-28	view